Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
1,278
Sort by:
dPCR Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
US$ 4,450.00
According to our new research study on “dPCR Market Forecast to 2031 –Global Analysis – by Product, Application, and End User,” the market is anticipated to grow from US$7.52 billion in 2024 to US$14....
January 2026
269 pages
RT-PCR Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
US$ 4,450.00
According to our new research study on “RT-PCR Market Forecast to 2031 –Global Analysis – by Product, Application, and End User,” the market is anticipated to grow from US$2.71 billion in 2024 to US$4...
January 2026
274 pages
Epigenetic Diagnostics Market - Forecast from 2026 to 2031
US$ 3,950.00
The Epigenetic Diagnostics Market is projected to grow significantly during the forecast period (2026-2031). The Epigenetic Diagnostics market is emerging as a transformative segment within molecular...
January 2026
148 pages
Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker (Exosomes, Circulating Nucleic Acids, CTC), By Technology, By Sample Type, By Application, By Clinical Application, By End Use, By Product, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global liquid biopsy market size is expected to reach USD 5.96 billion by 2030, according to a new report by Grand ... period. Enhanced view of tumor provided by liquid biopsy technology is estimated to augment the market in coming years. While tissue biopsies have been standard for cancer ...
January 2026
150 pages
The 2027-2032 World Outlook for Molecular Diagnostics
US$ 1,195.00
This study covers the world outlook for molecular diagnostics across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
January 2026
287 pages
The 2027-2032 World Outlook for Nucleic Acid Testing
US$ 1,195.00
This study covers the world outlook for nucleic acid testing across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for nucleic acid testing. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Molecular Diagnostics (MDx)
US$ 1,195.00
This study covers the world outlook for molecular diagnostics (MDx) across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for molecular diagnostics (MDx). It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
289 pages
The 2027-2032 World Outlook for Quantitative Polymerase Chain Reaction (qPCR) Reagents
US$ 1,195.00
This study covers the world outlook for quantitative polymerase chain reaction (qPCR) reagents across more than 190 countries. ... or the P.I.E., for quantitative polymerase chain reaction (qPCR) reagents. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, ...
January 2026
307 pages
The 2027-2032 World Outlook for In-Vitro Colorectal Cancer Screening Tests
US$ 1,195.00
This study covers the world outlook for in-vitro colorectal cancer screening tests across more than 190 countries. For each year ... demand, or the P.I.E., for in-vitro colorectal cancer screening tests. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
291 pages
The 2027-2032 World Outlook for Digital PCR
US$ 1,195.00
This study covers the world outlook for digital PCR across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Molecular Diagnostics IVD
US$ 1,195.00
This study covers the world outlook for molecular diagnostics IVD across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Multiplexed Diagnostics
US$ 1,195.00
This study covers the world outlook for multiplexed diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Nucleic Acid Test Kits
US$ 1,195.00
This study covers the world outlook for nucleic acid test kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for PoC Molecular Diagnostics
US$ 1,195.00
This study covers the world outlook for PoC molecular diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
Real-time PCR, Digital PCR & End-point PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Quantitative, Digital, Endpoint), By Product (Consumables & Reagents, Instruments, Software & Services), By Application (Clinical, Research), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Real-time PCR, Digital PCR & End-point PCR Market will grow from USD 9.01 Billion in 2025 to USD 13.12 Billion by 2031 at a 6.46% CAGR. The Global Real-time PCR, Digital PCR & End-point PCR...
January 2026
185 pages
C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type (ELISA, Chemiluminescence Immunoassay), By Detection Range (hs-CRP, Conventional CRP), By Disease Area (Cancer, Lupus), By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global c-reactive protein (CRP) testing market size is expected to reach USD 1.77 billion by 2025, ... women is expected to play a major role in the CRP testing market over the forecast period. Increase in funds provided to academic ... is ultimately driving the growth of the C-reactive protein testing market.
January 2026
200 pages
Digital PCR Market - Forecast from 2026 to 2031
US$ 3,950.00
The digital PCR market is expected to expand at a 13.97% CAGR, reaching USD 2151.54 million in 2031 from USD 981.865 million in 2025. The digital PCR (dPCR) market represents a significant technologic...
January 2026
151 pages
Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location (Point Of Care, Self-Test), By Technology (PCR, ISH, INAAT), By Application (Oncology, Infectious Diseases), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... such as HPV and influenza is anticipated to be the key driver for molecular diagnostics market growth. Moreover, increasing demand for rapid and accurate ... key factors attributing to its large market share. Increasing demand for user-friendly, portable, and rapid analysis devices is a key factor resulting ...
December 2025
270 pages
Minimal Residual Disease Testing Market - 2024-2031
US$ 3,400.00
Minimal Residual Disease Testing Marketis is growing with a CAGR of 12.50% during the forecast period 2026-2035. The Minimal Residual Disease Testing Market emerges as a key focus in DataM Intelligenc...
December 2025
58 pages
HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies), By Application (Diagnostic Applications, Antibody Screening, Chimerism Monitoring, Research Applications, Others), By Transplant Type (Solid Organ Transplant, Soft Tissue Transplant) Region and Competition, 2020-2030F
US$ 4,500.00
The Global HLA Typing for Transplant Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.91% to reach USD 2.87 Billion by 2030. Human Leukocyte Antigen (HLA) typing for...
December 2025
185 pages
HLA Typing Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Technique (Molecular Assay, Sequenced-based Molecular Assay, Non-Molecular Assay), By Application (Diagnosis, Research), By Product (Instruments, Reagents & Consumables, Software & Services), By End User (Commercial Service Providers, Hospitals and Transplant Centers, Research Labs & Academic Institutes), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global HLA Typing Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.50% to reach USD 2.80 Billion by 2030. Human Leukocyte Antigen (HLA) typing constitutes the pro...
December 2025
185 pages
Middle East Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker, By Technology, By Sample Type, By Application, By Clinical Application, By End Use, By Product, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The Middle East liquid biopsy market size was valued at USD 104.76 million in 2024 and is projected to reach USD 233.95 billion by 2033, growing at a CAGR of 9.28% from 2025 to 2033. The market is dri...
November 2025
150 pages
Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering (Testing Services, Kits, Platform, Other consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Others), By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management), By Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free Nucleic Acids, Exosomes & Extracellular Vesicles), By Application (Oncological and Non-oncological), By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Liquid Biopsy Market, valued at USD 4.93 Billion in 2024, is projected to experience a CAGR of 12.50% to reach USD 9.99 Billion by 2030. The global liquid biopsy market focuses on diagnosti...
November 2025
185 pages
Minimal Residual Disease (MRD) Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Flow Cytometry, Polymerase Chain Reaction, Next Generation Sequencing, Others), By Application (Leukemia, Lymphoma, Multiple Myeloma, Others), By End User (Hospitals & Specialty Clinics, Academic & Research Institutions, Clinical Laboratories, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Minimal Residual Disease (MRD) Testing Market, valued at USD 1.45 Billion in 2024, is projected to experience a CAGR of 8.70% to reach USD 2.39 Billion by 2030. Minimal residual disease (MR...
November 2025
185 pages
EV-Based Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering (Kits & Assays, Services, Instruments), By Workflow (Sample Preparation, Sequencing, Data Analysis), By Technology (Isolation Technologies, Analysis Technologies), By Sample Type (Blood, Urine, Saliva, and Others), By End user (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global EV-Based Liquid Biopsy Market , valued at USD 91.12 Million in 2024, is projected to experience a CAGR of 9.74% to reach USD 159.14 Million by 2030. Extracellular vesicle (EV)-based liquid...
November 2025
185 pages
Automated Nucleic Acid Extraction Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Technology (Magnetic Bead-based, Column-based), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global automated nucleic acid extraction market size was valued at USD 3.22 billion in 2024 and is expected to reach USD 8.77 billion by 2033, registering a CAGR of 11.89% from 2025 to 2033. Conti...
November 2025
120 pages
India Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Test Location, By Technology, By Platform, By Application, By End Use, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The India molecular diagnostics market size was estimated at USD 1,054.80 million in 2024 and is projected to reach USD 1,717.27 million by 2033, growing at a CAGR of 5.63% from 2025 to 2033. The grow...
November 2025
150 pages
